United States · Financial press · Investor's Business Daily
Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs
Novo stock popped early Wednesday on better-than-expected third-quarter sales and profit thanks to resounding beats from its GLP-1 drugs. The post Novo Surges 5% After Walloping…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)